Gene: ZSCAN20
Official Full Name: zinc finger and SCAN domain containing 20provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11880 | ZSCAN20 Knockout cell line (HeLa) | Human | ZSCAN20 | 1:3~1:6 | Negative | Online Inquiry |
KO11881 | ZSCAN20 Knockout cell line (HCT 116) | Human | ZSCAN20 | 1:2~1:4 | Negative | Online Inquiry |
KO11882 | ZSCAN20 Knockout cell line (HEK293) | Human | ZSCAN20 | 1:3~1:6 | Negative | Online Inquiry |
KO11883 | ZSCAN20 Knockout cell line (A549) | Human | ZSCAN20 | 1:3~1:4 | Negative | Online Inquiry |
ZSCAN20 Gene Knockout Cell Lines are a cutting-edge biological research tool designed to facilitate the study of gene function and regulation. ZSCAN20, encoding a zinc finger protein, is implicated in various cellular processes, including transcriptional regulation and differentiation. These knockout cell lines have been engineered through the CRISPR-Cas9 gene-editing technique, resulting in the precise and irreversible disruption of the ZSCAN20 gene, allowing researchers to investigate its role in cellular mechanisms and disease pathways comprehensively.
The key function of ZSCAN20 Gene Knockout Cell Lines lies in their ability to provide a controlled environment where researchers can assess the cellular behavior, proliferation, and phenotypic characteristics resulting from the absence of the ZSCAN20 protein. This allows for the elucidation of its effects on developmental biology, cancer research, and potential therapeutic strategies. Such insights can lead to breakthroughs in understanding certain cancers, autoimmune disorders, and other conditions where gene regulation plays a critical role.
From a scientific perspective, the ability to directly observe and manipulate the cellular outcomes in ZSCAN20 knockout models significantly enhances experimental accuracy and reproducibility. Compared to traditional gene-silencing techniques such as RNA interference, which can yield transient and varying degrees of knockdown, our knockout cell lines provide a more stable and definitive approach, making them superior for long-term studies.
Researchers and clinicians will find ZSCAN20 Gene Knockout Cell Lines invaluable for their potential to uncover genetic interactions and network dynamics, ultimately contributing to novel diagnostic and therapeutic strategies. Our product is engineered under stringent quality control protocols, ensuring high performance and reliability in your research.
Your research and clinical advancements are supported by our company’s longstanding expertise in genetic engineering and development of biological tools. We are dedicated to advancing scientific understanding and therapeutic innovation through our innovative product offerings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.